AGENUS INC Assets Held-for-sale, Not Part of Disposal Group, Current
AGENUS INC (AGEN) had Assets Held-for-sale, Not Part of Disposal Group, Current of $0 as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent · last filed 2026-08-07
- 2026-06-30: Assets Held-for-sale, Not Part of Disposal Group, Current $0.00.
- 2026-03-31: Assets Held-for-sale, Not Part of Disposal Group, Current $0.00.
- 2025-12-31: Assets Held-for-sale, Not Part of Disposal Group, Current $121.55M.
- 2025-09-30: Assets Held-for-sale, Not Part of Disposal Group, Current $122.15M.
| Period end | Assets Held-for-sale, Not Part of Disposal Group, Current |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-07 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-11 |
| 2025-12-31 | $121.55M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $122.15M 10-Q · filed 2025-11-10 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |